Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC. Radiol Oncol [Internet]. 2025 Dec. 16 [cited 2026 Sep. 22];59(4):617-23. Available from: https://www.radioloncol.com/index.php/ro/article/view/4451